MiniMed Group Inc. Common Stock vs MaxLinear Inc. Common Stock — how do they compare? MiniMed Group Inc. Common Stock trades at $19.71 (market cap $5.57B), while MaxLinear Inc. Common Stock trades at $96.16 (market cap $8.50B). The key difference: MaxLinear Inc. Common Stock is the larger of the two by market cap, and MiniMed Group Inc. Common Stock is more actively traded (23,336,073 versus 4,008,439). Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 1 Days and MaxLinear Inc. Common Stock for 1 Days on average.
| MMED | MXL | |
|---|---|---|
Market Cap | $5.57B | $8.50B |
Volume | 23,336,073 | 4,008,439 |
Sector | Health | Technology |
52-Week High | $23.84 | $128.03 |
52-Week Low | $10.80 | $13.05 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.37B | $8.58B |
Trailing returns across standard periods
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →